All News
Gingival Inflammation Parallels Saliva “Cytokine Score”
Researchers at NYU College of Dentistry have developed a single score to describe the level of cytokines in the saliva, and this score is linked with the severity of clinical gum inflammation, according to a study
Read Article
New Laboratory Insights for the ANA+ Consult
A new study suggests that use of ELISA assays for CXCL-10 and IFN-α can predict which ANA+ individuals may progress to developing a systemic autoimmune rheumatic disease (SARD).
Read Article
Drug Safety Differences w/ New Therapies in RA
Safety outcomes for targeted synthetic or b/ts DMARDs used to treat RA were studied using data from the ARTIS registry.
https://t.co/U96LiasMhW https://t.co/f2oCHs04Q3
Links:
Dr. John Cush RheumNow ( View Tweet)
Comparison of MIS-C dz in kids and adults>21 (MISC - A). By Dr Susan Shenoi @RWCSmtg #rwcs23 https://t.co/jvsMLARkCA
Dr. John Cush RheumNow ( View Tweet)
Case reports of anifrolumab use in 2 pts w/ chronic, scarring discoid lupus unresponsive to steriods, HCQ, immunosuppressants & CTX. Case 1 SLEDAI from 13 to 2 in 24 weeks & CLASI-A from 26 to 3 in 20wks. Cs 2 CLASI-A decr 24 to 5 after 1 infusion https://t.co/JE3PVyskm4
Links:
Dr. John Cush RheumNow ( View Tweet)
Older Lupus Patients Need Follow-Up After Hospital Discharge
Medicare beneficiaries 65 and older with lupus faced dramatically higher mortality when they received no follow-up care during the month after a hospital stay, researchers found.
https://t.co/4mFctXGQH9 https://t.co/2Q1z03myud
Links:
Dr. John Cush RheumNow ( View Tweet)
It's time to play, know your numbers! You know that famous game we play almost every other week, every other year.
https://t.co/JgCJzSuzHZ https://t.co/oiyB8vCOuD
Links:
Dr. John Cush RheumNow ( View Tweet)
Study of 232 pediatric #SLE pts. Over 12 mos 47% achieved LLDAS & Damage seen in 40% after 6.2 yrs F/U. Getting to LLDAS w/in 12 mos is assoc w less damage. LLDAS w/in 12 mos more likely in Absence of renal involvement. https://t.co/pGethJCw4e https://t.co/eYpVueIKbf
Links:
Dr. John Cush RheumNow ( View Tweet)
Rheums: Treating #RA, Do you Consider/Use RA Rx guidelines?
Dr. John Cush RheumNow ( View Tweet)
On Dec. 19, 2022, the U.S. Food & Drug Administration (FDA) approved subcutaneous abaloparatide (Tymlos) for the treatment of men with osteoporosis at high risk of fracture https://t.co/igwxVCdKuo https://t.co/COSmDrsv4p
Links:
Dr. John Cush RheumNow ( View Tweet)
Alternatives to Vagal nerve stimulation Dr Eric Ruderman #RWCS23 @RWCSmtg https://t.co/zpJsh10LLQ
Dr. John Cush RheumNow ( View Tweet)
2nd study results with Implantable Vagal nerve stim in active #RA pts. Dr Eric Ruderman #RWCS23 https://t.co/S6aFSVjePD
Dr. John Cush RheumNow ( View Tweet)
Implantable Vagal nerve stimulation studied in 17 active #RA pts DAS ~6. Dr Eric Ruderman #RWCS23 https://t.co/Xn9Ur199nv
Dr. John Cush RheumNow ( View Tweet)
Dr Eric Ruderman #RWCS23
Bee Venom around since 1859, vaguely better than placebo https://t.co/3Xl7SZwQPm
Dr. John Cush RheumNow ( View Tweet)
ADA biosimilars: one is out now and seven due out by July. “It’s time to get onboard with biosimilars” @RheumNow @RWCSmtg #RWCS23
Dr. Rachel Tate uptoTate ( View Tweet)
Do you use TNFi in pregnant patients? @RheumNow #RWCS23 @RWCSmtg
Dr. Rachel Tate uptoTate ( View Tweet)
Low dose prednisolone in RA. GLORIA shows toxicity can be a real issue. @RWCSmtg @RheumNow #RWCS23 https://t.co/KstyKdjWn2
Dr. Rachel Tate uptoTate ( View Tweet)
2022 EULAR recs for RA treatment @RheumNow @RWCSmtg #RWCS23 https://t.co/nWCcFJyIhz
Dr. Rachel Tate uptoTate ( View Tweet)
Join us on 3/18 and 3/19 in Dallas, Texas, or virtually for RheumNow Live!
Among our 24 speakers, Dr. Sergio and Monica Schwartzman will cover All in the Family Rheumatology. Dr. Philip Conaghan will cover Insights into the Future of OA and more.
https://t.co/gAKQYxhTMY https://t.co/zMOGfhRrg2
Links:
Dr. John Cush RheumNow ( View Tweet)
Know Your Numbers! Have a chance to tune in to last week's podcast?
https://t.co/A6bYIahvBF https://t.co/ZAgZ3FvL0H
Links:
Dr. John Cush RheumNow ( View Tweet)